Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. (Q30363500)

20 June 2017

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. (English)

1 reference

20 June 2017

0 references

1 reference

1 reference

8

Geert Leroux-Roels

0 references

Mamadou Dramé

4

object named as

Mamadou Dramé

1 reference

20 June 2017

Isabel Leroux-Roels

1

1 reference

20 June 2017

Astrid Borkowski

2

1 reference

20 June 2017

Thomas Vanwolleghem

3

1 reference

20 June 2017

Frédéric Clement

5

1 reference

20 June 2017

Eliane Hons

6

1 reference

20 June 2017

Jeanne-Marie Devaster

7

1 reference

20 June 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

20 June 2017

1 reference

20 June 2017

370

1 reference

20 June 2017

580-589

1 reference

20 June 2017

9587

1 reference

Development and evaluation of influenza pandemic vaccines

20 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Vaccines against avian influenza--a race against time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Influenza pandemic preparedness: gauging from EU plans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

How prepared is Europe for pandemic influenza? Analysis of national plans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Avian influenza vaccines: what's all the flap?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Development of vaccines against influenza H5

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Three Indonesian clusters of H5N1 virus infection in 2005

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Squalene and squalane emulsions as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

In vitro supplementation with different tocopherol homologues can affect the function of immune cells in old mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Mechanism of age-associated up-regulation in macrophage PGE2 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Mitigation strategies for pandemic influenza in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

Strategies for mitigating an influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961297-5

7 January 2021

10.1016/S0140-6736(07)61297-5

Identifiers

DOI

1 reference

20 June 2017

1 reference